MedTrace Logo

Multidimensional Assessment of Dyspnea in Asthma

NCT04286906 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 133

Last updated 2023-01-26

No results posted yet for this study

Summary

Breathlessness is a symptom of asthma that occurs in relation with lower airway obstruction. However, this sensation is not specific of asthma and may be the expression of other disorders. In particular, it can testify to anxiety or hyperventilation, two disorders frequently associated with asthma. The systematic interpretation of dyspnea as a manifestation of asthma in asthmatic patients may lead to an inappropriate increase in asthma controllers.

Identifying the cause of dyspnea in asthmatic patients (airway obstruction, anxiety or hyperventilation) is therefore crucial for the clinician.

This could be facilitated by a multidimensional assessment of dyspnea, evaluating the kind of sensation felt by the patient (for example chest tightness, air hunger etc.) and emotions associated to respiratory sensations (for example anxiety, fear etc.).

The objectives of this project are to assess: (1) the sensory and affective dimensions of dyspnea in asthma and, (2) their connection to asthma control, anxiety and depression.

Conditions

Interventions

OTHER

Questionnaire

MultiDimensional Profile (MDP), Anxiety-Depression Hospital Scale (HADs), Nijmegen

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Cécile Chenivesse, MD PhD · CHU Lille

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-18
Primary Completion
2022-08-11
Completion
2022-08-11

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04286906 on ClinicalTrials.gov